Management team
Duncan McClure, M.S., COO |
I hold a M.S. in Nanosience and Microsystems at UNM. I am a materials engineer by training and have interned at the Jet Propulsion Laboratory and built valuable experience in technology development and testing. I was also the president of the Association of Aspiring Technology Entrepreneurs (AATE) from 2013-2014. While there, I worked with my colleague, Anh-Dung Le, to help bring in some paid, long lasting internships through collaboration with a high-tech recruiter.
|
Matthew Aaron, Business Development |
I am passionate about people. I have worked in business with members from different walks of life, and love connecting with people and hearing their stories,I started and ran a local business with revenues up to $500k within 2 years.
|
PETER E. RINN, J.D., Chief Strategist |
I am a social entrepreneur and a retired attorney with over 40 years’ experience in successfully starting-up, rejuvenating and leading programs / organizations in the business, nonprofit and public sectors. I “throw away the box” when creating innovative solutions to intractable problems and turn tough challenges into exciting opportunities. I was a designated driver before it was cool and am committed to stopping the carnage caused by drunk drivers.
|
ADVISORS
DR. FRANK ETSCORN
|
First patent holder for the nicotine patch for use in tobacco cessation. The patent was licensed to Ciba-Geigy, now Novartis, and sold as the Habitrol patch. It is also marketed over-the-counter by Walmart (Equate), Kroger and Walgreens. He was named in most influential Kentuckians of the 20th Century. Dr. Etscorn holds the Lexington Herald-Leader “Products of the Year” and “Innovation" awards for the Nicotine Patch.
|
DR. JAMES LEARY
|
Dr. Leary received his Ph.D. in Biophysics at Penn State University and was a Postdoctoral Fellow at Los Alamos National Laboratory. He was a professor, researcher and inventor for 37 years at University of Rochester Medical School, UTMB Galveston, and Purdue University. He also has 15 years' experience in development of biomolecular and nanotechnology-based biosensors with colorimetric, fluorescence, or plasmonic-based output signals.
|
